Cited by

• Better comparisons of antiepileptic drugs: what measures of efficacy?

  Chadwick D. Chadwick D. Pharm World Sci. 1997 Oct;19(5):214-6. doi: 10.1023/a:1008642623460. Pharm World Sci. 1997. PMID: 9368920 Review.
• Core Health Outcomes in Childhood Epilepsy (CHOICE): Development of a core outcome set using systematic review methods and a Delphi survey consensus.

  Crudgington H, Rogers M, Bray L, Carter B, Currier J, Dunkley C, Gibbon FM, Hughes D, Lyle S, Roberts D, Tudur Smith C, Gringras P, Pal DK, Morris C. Crudgington H, et al. Epilepsia. 2019 May;60(5):857-871. doi: 10.1111/epi.14735. Epub 2019 Apr 25. Epilepsia. 2019. PMID: 31021436 Free PMC article.
• Pregabalin add-on for drug-resistant focal epilepsy.

  Panebianco M, Bresnahan R, Hemming K, Marson AG. Panebianco M, et al. Cochrane Database Syst Rev. 2019 Jul 9;7(7):CD005612. doi: 10.1002/14651858.CD005612.pub4. Cochrane Database Syst Rev. 2019. Update in: Cochrane Database Syst Rev. 2022 Mar 29;3:CD005612. doi: 10.1002/14651858.CD005612.pub5. PMID: 31287157 Free PMC article. Updated.
• High-dose intravenous immunoglobulin treatment in cryptogenic West and Lennox-Gastaut syndrome; an add-on study.

  van Engelen BG, Renier WO, Weemaes CM, Strengers PF, Bernsen PJ, Notermans SL. van Engelen BG, et al. Eur J Pediatr. 1994 Oct;153(10):762-9. doi: 10.1007/BF01954498. Eur J Pediatr. 1994. PMID: 7813537 Clinical Trial.
• Evaluation of antiepileptic drug efficacy. A review of clinical trial design.

  Pledger GW, Schmidt D. Pledger GW, et al. Drugs. 1994 Oct;48(4):498-509. doi: 10.2165/00003495-199448040-00002. Drugs. 1994. PMID: 7528126 Review.